178 related articles for article (PubMed ID: 30221599)
41. Trypanothione-dependent peroxide metabolism in Trypanosoma cruzi different stages.
Carnieri EG; Moreno SN; Docampo R
Mol Biochem Parasitol; 1993 Sep; 61(1):79-86. PubMed ID: 8259135
[TBL] [Abstract][Full Text] [Related]
42. Ovothiol and trypanothione as antioxidants in trypanosomatids.
Ariyanayagam MR; Fairlamb AH
Mol Biochem Parasitol; 2001 Jul; 115(2):189-98. PubMed ID: 11420105
[TBL] [Abstract][Full Text] [Related]
43. Structural insights into the enzymes of the trypanothione pathway: targets for antileishmaniasis drugs.
Colotti G; Baiocco P; Fiorillo A; Boffi A; Poser E; Chiaro FD; Ilari A
Future Med Chem; 2013 Oct; 5(15):1861-75. PubMed ID: 24144416
[TBL] [Abstract][Full Text] [Related]
44. Synthesis and evaluation of substrate analogue inhibitors of trypanothione reductase.
Duyzend MH; Clark CT; Simmons SL; Johnson WB; Larson AM; Leconte AM; Wills AW; Ginder-Vogel M; Wilhelm AK; Czechowicz JA; Alberg DG
J Enzyme Inhib Med Chem; 2012 Dec; 27(6):784-94. PubMed ID: 22085139
[TBL] [Abstract][Full Text] [Related]
45. New spermine and spermidine derivatives as potent inhibitors of Trypanosoma cruzi trypanothione reductase.
Bonnet B; Soullez D; Davioud-Charvet E; Landry V; Horvath D; Sergheraert C
Bioorg Med Chem; 1997 Jul; 5(7):1249-56. PubMed ID: 9377084
[TBL] [Abstract][Full Text] [Related]
46. Identification of potential trypanothione reductase inhibitors among commercially available β-carboline derivatives using chemical space, lead-like and drug-like filters, pharmacophore models and molecular docking.
Rodríguez-Becerra J; Cáceres-Jensen L; Hernández-Ramos J; Barrientos L
Mol Divers; 2017 Aug; 21(3):697-711. PubMed ID: 28656524
[TBL] [Abstract][Full Text] [Related]
47. Trypanothione Metabolism as Drug Target for Trypanosomatids.
Piñeyro MD; Arias D; Parodi-Talice A; Guerrero S; Robello C
Curr Pharm Des; 2021; 27(15):1834-1846. PubMed ID: 33308115
[TBL] [Abstract][Full Text] [Related]
48. Trypanothione reductase from Trypanosoma cruzi. Catalytic properties of the enzyme and inhibition studies with trypanocidal compounds.
Jockers-Scherübl MC; Schirmer RH; Krauth-Siegel RL
Eur J Biochem; 1989 Mar; 180(2):267-72. PubMed ID: 2647489
[TBL] [Abstract][Full Text] [Related]
49. Purification and characterization of a trypanothione-glutathione thioltransferase from Trypanosoma cruzi.
Moutiez M; Aumercier M; Schöneck R; Meziane-Cherif D; Lucas V; Aumercier P; Ouaissi A; Sergheraert C; Tartar A
Biochem J; 1995 Sep; 310 ( Pt 2)(Pt 2):433-7. PubMed ID: 7654179
[TBL] [Abstract][Full Text] [Related]
50. The Thiol-polyamine Metabolism of Trypanosoma cruzi: Molecular Targets and Drug Repurposing Strategies.
Talevi A; Carrillo C; Comini M
Curr Med Chem; 2019; 26(36):6614-6635. PubMed ID: 30259812
[TBL] [Abstract][Full Text] [Related]
51. Effects of nifurtimox and benznidazole upon glutathione and trypanothione content in epimastigote, trypomastigote and amastigote forms of Trypanosoma cruzi.
Maya JD; Repetto Y; Agosín M; Ojeda JM; Tellez R; Gaule C; Morello A
Mol Biochem Parasitol; 1997 May; 86(1):101-6. PubMed ID: 9178272
[No Abstract] [Full Text] [Related]
52. The glyoxalase pathway in protozoan parasites.
Sousa Silva M; Ferreira AE; Gomes R; Tomás AM; Ponces Freire A; Cordeiro C
Int J Med Microbiol; 2012 Oct; 302(4-5):225-9. PubMed ID: 22901378
[TBL] [Abstract][Full Text] [Related]
53. Kinetic modeling can describe in vivo glycolysis in Entamoeba histolytica.
Saavedra E; Marín-Hernández A; Encalada R; Olivos A; Mendoza-Hernández G; Moreno-Sánchez R
FEBS J; 2007 Sep; 274(18):4922-40. PubMed ID: 17824961
[TBL] [Abstract][Full Text] [Related]
54. Targeting the polyamine biosynthetic enzymes: a promising approach to therapy of African sleeping sickness, Chagas' disease, and leishmaniasis.
Heby O; Persson L; Rentala M
Amino Acids; 2007 Aug; 33(2):359-66. PubMed ID: 17610127
[TBL] [Abstract][Full Text] [Related]
55. Glyoxalase II does not support methylglyoxal detoxification but serves as a general trypanothione thioesterase in African trypanosomes.
Wendler A; Irsch T; Rabbani N; Thornalley PJ; Krauth-Siegel RL
Mol Biochem Parasitol; 2009 Jan; 163(1):19-27. PubMed ID: 18848584
[TBL] [Abstract][Full Text] [Related]
56. Preparative enzymatic synthesis of trypanothione and trypanothione analogues.
Comini MA; Dirdjaja N; Kaschel M; Krauth-Siegel RL
Int J Parasitol; 2009 Aug; 39(10):1059-62. PubMed ID: 19477177
[TBL] [Abstract][Full Text] [Related]
57. Discovery of novel polyamine analogs with anti-protozoal activity by computer guided drug repositioning.
Alberca LN; Sbaraglini ML; Balcazar D; Fraccaroli L; Carrillo C; Medeiros A; Benitez D; Comini M; Talevi A
J Comput Aided Mol Des; 2016 Apr; 30(4):305-21. PubMed ID: 26891837
[TBL] [Abstract][Full Text] [Related]
58. Design, synthesis, and biological evaluation of phosphinopeptides against Trypanosoma cruzi targeting trypanothione biosynthesis.
Ravaschino EL; Docampo R; Rodriguez JB
J Med Chem; 2006 Jan; 49(1):426-35. PubMed ID: 16392828
[TBL] [Abstract][Full Text] [Related]
59. Metabolic control analysis: a tool for designing strategies to manipulate metabolic pathways.
Moreno-Sánchez R; Saavedra E; Rodríguez-Enríquez S; Olín-Sandoval V
J Biomed Biotechnol; 2008; 2008():597913. PubMed ID: 18629230
[TBL] [Abstract][Full Text] [Related]
60. Identification of Novel Chemical Scaffolds Inhibiting Trypanothione Synthetase from Pathogenic Trypanosomatids.
Benítez D; Medeiros A; Fiestas L; Panozzo-Zenere EA; Maiwald F; Prousis KC; Roussaki M; Calogeropoulou T; Detsi A; Jaeger T; Šarlauskas J; Peterlin Mašič L; Kunick C; Labadie GR; Flohé L; Comini MA
PLoS Negl Trop Dis; 2016 Apr; 10(4):e0004617. PubMed ID: 27070550
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
